Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

merck sharp & dohme corp. - sodium selenite (unii: hiw548rq3w) (selenite ion - unii:kxo0259xj1), .alpha.-tocopherol acetate, d- (unii: a7e6112e4n) (.alpha.-tocopherol, d- - unii:n9pr3490h9) - indications e-se injection is recommended for the control of the following clinical signs when associated with myositis (selenium-tocopherol deficiency) syndrome: rapid respiration, profuse sweating, muscle spasms and stiffness, elevated sgot.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

merck sharp & dohme corp. - sodium selenite (unii: hiw548rq3w) (selenite ion - unii:kxo0259xj1), .alpha.-tocopherol acetate, d- (unii: a7e6112e4n) (.alpha.-tocopherol, d- - unii:n9pr3490h9) - for veterinary use only indications bo-se (selenium, vitamin e) is recommended for the prevention and treatment of white muscle disease (selenium-tocopherol deficiency) syndrome in calves, lambs, and ewes. clinical signs are: stiffness and lameness, diarrhea and unthriftiness, pulmonary distress and/or cardiac arrest. in sows and weanling pigs, as an aid in the prevention and treatment of diseases associated with selenium-toco pherol deficiency, such as hepatic necrosis, mulberry heart disease, and white muscle disease. where known deficiencies of selenium and/or vitamin e exist, it is advisable, from the prevention and control standpoint, to inject the sow during the last week of pregnancy. contraindications do not use in pregnant ewes. deaths and abortions have been reported in pregnant ewes injected with this product.

Филипини - Енглески - FDA (Food And Drug Administration)

crisdy-na drug corporation; distributor: n/a - ascorbic acid , d-alpha tocopherol (vitamin e) , beta carotene , zinc - softgel capsule - formulation each softgel capsule contains: ascorbic acid-175 mg ascorbic acid-125 mg (equivalent to 302.58 mg calcium ascorbate) d-alpha tocopherol-250 iu (vitamin e) beta carotene-10 mg zinc-10 mg (equivalent to 27.5 mg zinc sulfate monohydrate)

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi-aventis consumer healthcare - d-alpha-tocopherol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - d-alpha-tocopherol,tocopherols concentrate - mixed (high-alpha type) -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - d-alpha-tocopherol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi-aventis consumer healthcare - d-alpha-tocopherol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi-aventis consumer healthcare - d-alpha-tocopherol -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - d-alpha-tocopherol -

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - rivastigmine 18mg;  ;   - transdermal patch - 9.5 mg/24h - active: rivastigmine 18mg     excipient: dimeticone dl-alpha tocopherol acrylic pressure sensitive adhesive silicone pressure sensitive adhesive backing film 10 cm square release liner 20.25 cm square poly(butyl methacrylate-co-methyl methacrylate) - treatment of patients with: · mild to moderately severe dementia of the alzheimer's type (also termed probable alzheimer's disease or alzheimer's disease) · severe dementia of the alzheimer's type.